000 01744 a2200457 4500
005 20250515023404.0
264 0 _c20060626
008 200606s 0 0 eng d
022 _a1523-6838
024 7 _a10.1053/j.ajkd.2006.01.017
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Philip Kam-Tao
245 0 0 _aHong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
_h[electronic resource]
260 _bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_cMay 2006
300 _a751-60 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAngiotensin II Type 1 Receptor Blockers
_xtherapeutic use
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aGlomerulonephritis, IGA
_xdrug therapy
650 0 4 _aHong Kong
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aTetrazoles
_xtherapeutic use
650 0 4 _aValine
_xanalogs & derivatives
650 0 4 _aValsartan
700 1 _aLeung, Chi Bon
700 1 _aChow, Kai Ming
700 1 _aCheng, Yuk Lun
700 1 _aFung, Samuel Ka-Shun
700 1 _aMak, Siu Ka
700 1 _aTang, Anthony Wing-Chung
700 1 _aWong, Teresa Yuk-Hwa
700 1 _aYung, Chun Yu
700 1 _aYung, Jonathan Chee-Unn
700 1 _aYu, Alex Wai-Yin
700 1 _aSzeto, Cheuk Chun
773 0 _tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_gvol. 47
_gno. 5
_gp. 751-60
856 4 0 _uhttps://doi.org/10.1053/j.ajkd.2006.01.017
_zAvailable from publisher's website
999 _c16235768
_d16235768